Urinary biomarkers for the diagnosis of cervical cancer by quantitative label-free mass spectrometry analysis. Chokchaichamnankit D, Watcharatanyatip K, Subhasitanont P, Weeraphan C, Keeratichamroen S, Sritana N, Kantathavorn N, Diskul-Na-Ayudthaya P, Saharat K, Chantaraamporn N, Verathamjamras C, Phoolcharoen N, Wiriyaukaradecha K, Paricharttanakul NM, Udomchaiprasertkul W, Sricharunrat T, Auewarakul C, Svasti J. and Srisomsap C*. Oncol Lett. 2019 Jun;17(6):5453-5468.

01 Jun 2019
0

Urinary biomarkers for the diagnosis of cervical cancer by quantitative label-free mass spectrometry analysis. 

Chokchaichamnankit D, Watcharatanyatip K, Subhasitanont P, Weeraphan C,  Keeratichamroen S, Sritana N, Kantathavorn N, Diskul-Na-Ayudthaya P, Saharat K, Chantaraamporn N, Verathamjamras C, Phoolcharoen N, Wiriyaukaradecha K, Paricharttanakul NM, Udomchaiprasertkul W, Sricharunrat T, Auewarakul C, Svasti J. and Srisomsap C*. 

Oncol Lett. 2019 Jun;17(6):5453-5468.

Tags

Share this

Related Posts

Identifying important life stages for monitoring and assessing risks from exposures to environmental contaminants: Results of a World Health Organization review. Cohen Hubal, E. A., de Wet, T., Du Toit, L., Firestone, M. P., Ruchirawat, M., van Engelen, J., & Vickers, C. (2014). Regulatory Toxicology and Pharmacology, 69(1), 113-124.

Recent Posts